Innovating Works

FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA

Inactiva
Mostrando 1 al 20 de 135 resultados
VIDA: VHIO International postDoctoral programme for translAtional research FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | Financiado
Adaptmet: Deconstructing adaptive evolution of metastasis Adaptmet aims to develop an advanced training program encompassing the multifaceted aspects of metastasis adaptation mechanisms, intending t...
2024-07-05 - 2029-02-28 | Financiado
Novel GIST Therapies: Targeted Protein Degradation as a Therapeutic Strategy for the Treatment of Gastrointestinal Stromal... FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Gastrointestinal stromal tumour (GIST) is the most common subtype of sarcoma in humans and its initiation and progression is predominantly d...
2024-04-25 - 2027-02-28 | Financiado
IRB-TARGET: IRB Barcelona International PhD programme on TARGET for high impact biomedicine FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01 IRB Barcelona (IRB) is an independent, non-profit research centre engaged in basic and applied biomedical science. The IRB-TARGET doctoral p...
2023-09-13 - 2029-08-31 | Financiado
PalmitoMet: Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic Cancer FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: ERC-2023-POC Despite recent breakthroughs in immunotherapy and cancer research, metastasis continues to be responsible for 90% of cancer related deaths....
2023-08-20 - 2025-05-31 | Financiado
MultiSeq: Computational multiplexing to optimise next generation sequencing BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION tramitó un HORIZON EUROPE: ERC-2023-POC Recent advances in Next-Generation Sequencing (NGS) of nucleic acids (i.e. DNA or RNA) have transformed biology and medicine. Today NGS is o...
2023-05-25 - 2025-05-31 | Financiado
PROSTarget: PROSTarget Understanding the aggressive nature and key molecular drivers of metastatic disseminatio... FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Cancer cells dissemination from primary tumors to distant sites is the most terrifying evolving process of cancer. Such an irreversible and...
2023-03-17 - 2025-06-30 | Financiado
EpiHTStem: Understanding the Maintenance and Heritability of Hematopoietic Stem Cell Memories High Throughput... FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 During the development of multicellular organisms, cells from the same niche can be stochastically exposed to different signals and stimuli,...
2023-03-13 - 2025-03-31 | Financiado
ONCO-COMP: Oncogenic competence during development – When, Where and Why? FUNDACIO PRIVADA PER LA RECERCA I LA DOCENCIA SANT JOAN DE DEU tramitó un HORIZON EUROPE: ERC-2022-STG Childhood cancers are believed to be rooted in aberrant development, a notion supported by their (i) generally low mutational burden, (ii) h...
2023-01-12 - 2028-08-31 | Financiado
EOSC4Cancer: A European wide foundation to accelerate Data driven Cancer Research BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION tramitó un HORIZON EUROPE: HORIZON-INFRA-2021-EOSC-01 Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Euro...
2022-06-09 - 2025-02-28 | Financiado
CGI-Clinics: Data driven cancer genome interpretation for personalised cancer treatment FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advis...
2022-05-20 - 2027-10-31 | Financiado
PERSIST-SEQ: Building a reproducible single cell experimental workflow to capture tumour cell persistence STICHTING WOMEN ENGAGE FOR ACOMMON FUTURE - INTERNATIONAL tramitó un H2020: H2020-JTI-IMI2-2020-20-two-stage It is the ambition of PRESIST-SEQ to provide a new gold standard in single-cell experimental workflows the cancer research community by deve...
2021-06-28 - 2026-06-30 | Financiado
DECIDER: Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance... HELSINGIN YLIOPISTO tramitó un H2020: H2020-SC1-BHC-2018-2020 The goals of this inter-disciplinary project are to 1) gain understanding of the mechanisms causing chemoresistance in high-grade serous ova...
2021-01-21 - 2026-07-31 | Financiado
SENFIB: Novel senolytic drugs for the treatment of lung and kidney fibrosis FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un H2020: ERC-2020-PoC SENFIB aims to deliver new drugs for the treatment of fibrotic diseases. Nearly one quarter of the global population will be over the age o...
2020-12-14 - 2022-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.